Tristel plc (AIM:TSTL)
402.50
+2.50 (0.63%)
At close: Jan 22, 2026
Tristel Market Cap
Tristel has a market cap or net worth of 191.4 million as of January 22, 2026. Its market cap has decreased by -6.67% in one year.
Market Cap
191.40M
Enterprise Value
184.43M
Revenue
46.46M
Ranking
n/a
PE Ratio
28.92
Stock Price
402.50
Market Cap Chart
Since June 1, 2005, Tristel's market cap has increased from 6.91M to 191.40M, an increase of 2,671.10%. That is a compound annual growth rate of 17.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 191.40M | -4.02% |
| Dec 31, 2025 | 199.42M | -1.61% |
| Dec 31, 2024 | 202.69M | -7.08% |
| Dec 29, 2023 | 218.13M | 18.41% |
| Dec 30, 2022 | 184.21M | -14.20% |
| Dec 31, 2021 | 214.69M | -12.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.68B |
| GSK plc | 72.04B |
| Haleon | 33.21B |
| Smith & Nephew | 10.20B |
| Avacta Group | 229.72M |
| Faron Pharmaceuticals Oy | 198.16M |
| Optima Health | 192.64M |
| Animalcare Group | 175.38M |